These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12881465)

  • 1. Sample preparation in patients receiving uric acid oxidase (rasburicase) therapy.
    Lim E; Bennett P; Beilby J
    Clin Chem; 2003 Aug; 49(8):1417-9. PubMed ID: 12881465
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.
    Coiffier B; Mounier N; Bologna S; Fermé C; Tilly H; Sonet A; Christian B; Casasnovas O; Jourdan E; Belhadj K; Herbrecht R;
    J Clin Oncol; 2003 Dec; 21(23):4402-6. PubMed ID: 14581437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perchloric acid treatment to stabilize uric acid concentrations in blood samples of patients receiving uric acid oxidase (rasburicase) therapy.
    Stove V; Wuyts B; Delanghe J
    Clin Chem; 2007 Feb; 53(2):369-70. PubMed ID: 17259256
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma.
    Pui CH; Mahmoud HH; Wiley JM; Woods GM; Leverger G; Camitta B; Hastings C; Blaney SM; Relling MV; Reaman GH
    J Clin Oncol; 2001 Feb; 19(3):697-704. PubMed ID: 11157020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of hyperuricemia with rasburicase in children with leukemia and non-Hodgkin's lymphoma.
    Rényi I; Bárdi E; Udvardi E; Kovács G; Bartyik K; Kajtár P; Masát P; Nagy K; Galántai I; Kiss C
    Pathol Oncol Res; 2007; 13(1):57-62. PubMed ID: 17387390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies.
    Pui CH; Relling MV; Lascombes F; Harrison PL; Struxiano A; Mondesir JM; Ribeiro RC; Sandlund JT; Rivera GK; Evans WE; Mahmoud HH
    Leukemia; 1997 Nov; 11(11):1813-6. PubMed ID: 9369411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rasburicase.
    Easton J; Noble S; Jarvis B
    Paediatr Drugs; 2001; 3(6):433-7; discussion 438-9. PubMed ID: 11437188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of urinary allantoin by capillary zone electrophoresis during recombinant urate oxydase (rasburicase) therapy.
    Kattygnarath D; Mounier N; Madelaine-Chambrin I; Gourmel B; Le Bricon T; Gisselbrecht C; Faure P; Houzé P
    Clin Biochem; 2006 Jan; 39(1):86-90. PubMed ID: 16316640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of hyperuricemia in hematological malignancies.
    Cairo MS
    Clin Lymphoma; 2002 Dec; 3 Suppl 1():S26-31. PubMed ID: 12521386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rasburicase (Fasturtec)].
    Vogt B; Gugger M; Frey FJ
    Ther Umsch; 2004 Sep; 61(9):579-82. PubMed ID: 15493120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapy.
    Liu CY; Sims-McCallum RP; Schiffer CA
    Leuk Res; 2005 Apr; 29(4):463-5. PubMed ID: 15725482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study.
    Bosly A; Sonet A; Pinkerton CR; McCowage G; Bron D; Sanz MA; Van den Berg H
    Cancer; 2003 Sep; 98(5):1048-54. PubMed ID: 12942574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refrigeration is not necessary for measurement of uric acid in patients treated with rasburicase.
    Lindeman NI; Melanson SE; McDonnell A; DeAngelo DJ; Jarolim P
    Clin Chem Lab Med; 2013 May; 51(5):1053-7. PubMed ID: 23079515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of rasburicase (recombinant urate oxidase) in the prevention and treatment of malignancy-associated hyperuricemia: an Indian experience.
    Digumarti R; Sinha S; Nirni SS; Patil SG; Pedapenki RM
    Indian J Cancer; 2014; 51(2):180-3. PubMed ID: 25104205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant urate oxidase (Rasburicase) for the treatment of hyperuricemia in pediatric patients with hematologic malignancies: Results of a compassionate prospective multicenter study in Korea.
    Shin HY; Kang HJ; Park ES; Choi HS; Ahn HS; Kim SY; Chung NG; Kim HK; Kim SY; Kook H; Hwang TJ; Lee KC; Lee SM; Lee KS; Yoo KH; Koo HH; Lee MJ; Seo JJ; Moon HN; Ghim T; Lyu CJ; Lee WS; Choi YM
    Pediatr Blood Cancer; 2006 Apr; 46(4):439-45. PubMed ID: 16123985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Therapeutic Effect of Rasburicase on Hyperuricemia Associated with Chemotherapy Based on Theoretical Model.
    Kimura K; Kanehira N; Takayanagi R; Minohara H; Homma M; Yamada Y
    Biol Pharm Bull; 2016; 39(5):705-11. PubMed ID: 27150142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.
    Cheuk DK; Chiang AK; Chan GC; Ha SY
    Cochrane Database Syst Rev; 2014 Aug; (8):CD006945. PubMed ID: 25121561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis.
    Lopez-Olivo MA; Pratt G; Palla SL; Salahudeen A
    Am J Kidney Dis; 2013 Sep; 62(3):481-92. PubMed ID: 23684124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy.
    Hutcherson DA; Gammon DC; Bhatt MS; Faneuf M
    Pharmacotherapy; 2006 Feb; 26(2):242-7. PubMed ID: 16466328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of single-dose rasburicase in an obese female.
    Arnold TM; Reuter JP; Delman BS; Shanholtz CB
    Ann Pharmacother; 2004 Sep; 38(9):1428-31. PubMed ID: 15292497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.